The risk treatment plan is explicitly listed in Appendix C and requires governing/management approval under ID.RA-06 point 3. Its purpose is to translate risk-assessment outcomes into prioritized, owned, and time-bound actions with measurable closure evidence.
Key takeaways
- A treatment plan is mandatory and approval-driven, not a purely operational backlog.
- Each planned action should be traceable to assessed risk and residual-risk rationale.
- Governance value comes from prioritization quality, ownership clarity, and deadline discipline.
- A template structure should enforce consistency across mitigation, transfer, acceptance, and avoidance strategies.
What an approvable ID.RA-06 treatment plan must show
| Objective | Minimum output | Evidence |
|---|---|---|
| Risk linkage | Every action linked to a risk ID | Risk-to-action mapping table |
| Ownership | Named accountable owner per action | Action register with owners |
| Time discipline | Start date, milestone, due date | Delivery tracker and status logs |
| Decision transparency | Treatment strategy + rationale | Approval minutes and exception records |
Practical plan structure
1. Purpose, scope, and references
State the plan is the treatment layer of ID.RA-05 outcomes and define covered systems/services.
2. Treatment decision model
Define accepted strategies: mitigate, transfer, avoid, accept, and decision criteria.
3. Prioritized action portfolio
List actions by risk criticality, dependencies, and execution sequence.
4. Ownership and governance
Assign accountable owners, escalation paths, and reporting cadence.
5. Milestones and closure criteria
Define what counts as completed treatment and which evidence proves closure.
6. Residual-risk management
Document accepted residual risk with approver and review date.
7. Plan update cycle
Set recurring review cadence and re-prioritization triggers.
Typical plan-quality failures
- Actions listed without risk IDs.
- Due dates present but no accountable owner.
- Risk acceptance used without formal rationale and approver.
- No dependency mapping, causing blocked actions and delays.
- Closure declared without evidence criteria.
20-day treatment-plan hardening checklist
- Import top risks from approved assessment with stable IDs.
- Classify treatment strategy for each risk and document rationale.
- Assign owner, target date, and milestone for every action.
- Define evidence required to mark each action closed.
- Add residual-risk acceptance workflow with formal sign-off.
- Submit consolidated plan for governing-body approval.
FAQ
Is the treatment plan a mandatory board-approval document?
Yes. Appendix C lists the risk treatment plan with reference ID.RA-06 point 3.
Can one treatment plan cover multiple domains?
Yes, if risk traceability and ownership remain clear. Many teams use one master plan with domain-specific sections.
How often should priorities be updated?
At least on scheduled governance cycles and whenever risk posture changes materially.
Conclusion and next steps
A solid ID.RA-06 plan turns risk analysis into accountable delivery. The priority is to keep risk-to-action traceability explicit, enforce ownership discipline, and require evidence-based closure before declaring risk reduction achieved.
Related reading
- NIS2 mandatory documents master guide: what must be approved by the board and what to prepare now
- NIS2 risk assessment document for systems and networks: practical guide for ID.RA-05 approval
- NIS2 remediation roadmap (Piano di Adeguamento): practical guide for ID.IM-01 approval
- Aegister NIS2 Compliance Service
- Cyber Check-up
